NCT06613568Recruiting
Moda-flx Hemodialysis System™ Under Professional Care Settings by Trained Individuals and At Home by Participants
Prospective, Non-Randomized, Multicenter, Open-Label Study Evaluating the Use of the Moda-flx Hemodialysis System™ Under Professional Care and At Home by Participants With End Stage Kidney Disease (ESKD) Who Are on Stable Dialysis Regimens
Source: ClinicalTrials.gov · Last updated 6 Jul 2026
Brief summary (registry, in English)
The purpose of this study is to evaluate the safety and efficacy of the Moda-flx Hemodialysis System™ when used Under Professional Care Settings by trained individuals and At Home by trained Participants and Care Partners
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- First submitted
- 23 Sept 2024
- Start date
- 6 Oct 2025
- Primary completion date
- Mar 2027
- Lead sponsor
- Diality Inc.
- Diseases
- Chronic kidney disease
- NCT number
- NCT06613568
What you commit to
- Study type: Interventional
- Planned participants: 50
- From 6 Oct 2025 to the primary completion date, Mar 2027
- 5 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Symptomatic intradialytic hypotension requiring medical intervention (ultrafiltration turned off, bolus of fluid) in at least two treatments during the Run-In period defined as:
- Persistent pre-dialysis sitting SBP \< 100 mmHg despite medical therapy,
- Nadir intradialytic Systolic Blood Pressure (SBP) \< 90 mmHg, if Subject's pre-HD SBP \< 160 mmHg
- Nadir intradialytic SBP \< 100 mmHg if Subject's pre-HD SBP ≥ 160 mmHg
- Participant had an average ultrafiltration rate \> 13 mL/kg/hour during the last 2 weeks prior to Screening, per medical records.
- Had a significant cardiovascular adverse event within the last 90 days prior to Screening.
Other illness
- Documented history of non-adherence to dialysis therapy that would prevent successful completion of the study
Lab values
- Hgb level of \< 9 g/dL at Screening
Who the study is looking for
- Are between 18 and 80 years of age and Care Partner is at least 18 years of age at the time of signing consent.
- Have a diagnosis of end stage kidney disease (ESKD) adequately treated by maintenance dialysis (defined as achieving a spKt/V ≥ 1.2 OR stdKt/V ≥ 2.1) and be deemed stable by their treating nephrologist prior to the end of the Screening Period
- Have a well-functioning and stable vascular access (tunneled central venous catheter arteriovenous fistula, or graft) that allows a blood flow of at least 300 ml/min prior to the end of Screening
- Can successfully complete a Skills and Comprehension Assessment with a Care Partner prior to the completion of the Training Period.
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (5)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| aQua Research Institute, LLC Coordinator of this site? Confirm its status | Houston | United States | Recruiting |
| Nephrology Associates of Knoxville Coordinator of this site? Confirm its status | Knoxville | United States | Recruiting |
| New York Kidney Hypertension Medicine Coordinator of this site? Confirm its status | New Hyde Park | United States | Recruiting |
| North America Research Institute Coordinator of this site? Confirm its status | San Dimas | United States | Recruiting |
| University of Washington Coordinator of this site? Confirm its status | Seattle | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.